Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Cost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Lexington (CDIX) Shares Outstanding (Diluted Average) (2019 - 2025)

Cardiff Lexington's Shares Outstanding (Diluted Average) history spans 10 years, with the latest figure at $17.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 27.15% year-over-year to $17.9 million; the TTM value through Sep 2025 reached $17.9 million, up 27.15%, while the annual FY2024 figure was $11.4 million, 76179.12% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $17.9 million in Q3 2025 per CDIX's latest filing, up from $17.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $189.1 million in Q3 2022 to a low of $5822.0 in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $53.0 million, with a median of $15.3 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): tumbled 100.0% in 2022, then soared 76179.12% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $128.0 million in 2021, then crashed by 100.0% to $5822.0 in 2022, then surged by 157.66% to $15001.0 in 2023, then skyrocketed by 76179.12% to $11.4 million in 2024, then soared by 56.41% to $17.9 million in 2025.
  • Per Business Quant, the three most recent readings for CDIX's Shares Outstanding (Diluted Average) are $17.9 million (Q3 2025), $17.0 million (Q2 2025), and $15.3 million (Q1 2025).